Jump to main content
Jump to site search

Issue 3, 2014
Previous Article Next Article

Photosensitizer-conjugated redox-responsive dextran theranostic nanoparticles for near-infrared cancer imaging and photodynamic therapy

Author affiliations

Abstract

Photodynamic therapy (PDT) has emerged as an effective treatment for tumor with minimal nonspecific damage to adjacent healthy tissues. Herein, redox-responsive self-quenching polysaccharide-based theranostic nanoparticles (DEX-SS-Ce6 NPs) were developed for tumor imaging and photodynamic therapy. The dextran–chlorin e6 conjugates (DEX-SS-Ce6) could self-assemble into nanoparticles with uniform sphere shape in aqueous solution and exhibit cellular redox-responsive “OFF/ON” behavior of a fluorescence signal. In addition, the DEX-SS-Ce6 NPs demonstrated an effective cellular uptake property and high phototoxicity upon near-infrared (NIR) laser irradiation. More importantly, DEX-SS-Ce6 NP treated mice presented enhanced tumor targeting ability and improved photodynamic therapeutic efficiency in an in vivo study, compared with free Ce6 treated mice. These results suggest that the DEX-SS-Ce6 NP is a great potential system for tumor imaging and photodynamic therapy.

Graphical abstract: Photosensitizer-conjugated redox-responsive dextran theranostic nanoparticles for near-infrared cancer imaging and photodynamic therapy

Back to tab navigation

Article information


Submitted
29 Aug 2013
Accepted
19 Sep 2013
First published
20 Sep 2013

Polym. Chem., 2014,5, 874-881
Article type
Paper

Photosensitizer-conjugated redox-responsive dextran theranostic nanoparticles for near-infrared cancer imaging and photodynamic therapy

P. Liu, C. Yue, Z. Sheng, G. Gao, M. Li, H. Yi, C. Zheng, B. Wang and L. Cai, Polym. Chem., 2014, 5, 874
DOI: 10.1039/C3PY01173A

Social activity

Search articles by author

Spotlight

Advertisements